BMS Asks High Court To Review Hepatitis Drug Patent Row
Bristol-Myers Squibb Co. has urged the U.S. Supreme Court to review whether courts should consider evidence presented after the filing of a patent application that shows differences between an invention and...To view the full article, register now.
Already a subscriber? Click here to view full article